On March 20, Chuansha New Town grandly held the 2024 Enterprise Commendation Event and Investment Promotion Launching Ceremony. At the meeting, Medicilon (Chuansha) Inc., a subsidiary of Shanghai Medicilon Inc. (Medicilon), relied on its outstanding performance and strong development momentum in the field of biopharmaceutical, won the "Development Potential Award" for the 2023 Chuansha New Town Economic Work Advanced Unit. As a one-stop biopharmaceutical preclinical R&D service platform, Medicilon is well-deserved for the award. Over the past two decades, Medicilon has been deeply involved in the field of biopharmaceutical preclinical research and development. Medicilon has not only continue to shine in the field of traditional chemical drugs, but also proactively planning ahead in emerging tracks such as bi/multi-specific antibodies , ADCs , PROTACs , mRNA vaccines, small nucleic acid drugs, cells and immunity, and have built a series of e...
Integrated Drug Discovery Services- Chemistry, Biology & Preclinical Services